These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34321916)

  • 1. Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma.
    Lu X; Li G; Liu S; Wang H; Zhang Z; Chen B
    Int J Gen Med; 2021; 14():3707-3717. PubMed ID: 34321916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
    Chen B; Gao C; Wang H; Sun J; Han Z
    Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining.
    Chen Y; Tian D; Chen X; Tang Z; Li K; Huang Z; Fu Y; Feng Y; Yang Z
    Int J Gen Med; 2021; 14():967-981. PubMed ID: 33790626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer.
    Xie B; Tan G; Ren J; Lu W; Pervaz S; Ren X; Otoo AA; Tang J; Li F; Wang Y; Wang M
    Front Oncol; 2022; 12():830908. PubMed ID: 35299734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
    Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
    [No Abstract]   [Full Text] [Related]  

  • 7. KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer.
    Han M; Yang HJ; Lin Q
    Math Biosci Eng; 2019 Dec; 17(2):1702-1717. PubMed ID: 32233603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
    Diao B; Yang P
    Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
    Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
    Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of
    Qi B; Liu S; Liu D; Yao H; Yan R
    Dis Markers; 2022; 2022():2687867. PubMed ID: 35140819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments.
    Gao L; Li X; Guo Q; Nie X; Hao Y; Liu Q; Liu J; Zhu L; Yan L; Lin B
    Cancer Cell Int; 2020; 20():509. PubMed ID: 33088217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
    Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
    J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
    Zhang P; Su T; Zhang S
    J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
    Zuo L; Li X; Tan Y; Zhu H; Xiao M
    J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses.
    Cao W; Wang C; Zhang Y; Yang J; Luo X; Zhao Y; Wu M; Cheng S; Wang Y
    Eur J Med Res; 2024 Mar; 29(1):166. PubMed ID: 38475882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDC80 Kinetochore Complex Serves as a Potential Prognostic Predictor and Correlates with Immune Infiltrates in Epithelial Ovarian Cancer Patients.
    Yu X; Pan M; Jiang L; Liu K
    Int J Gen Med; 2024; 17():1789-1805. PubMed ID: 38711823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma.
    Deng Y; Zhang L; Dai C; Xu Y; Gan Q; Cheng J
    J Gynecol Oncol; 2024 Mar; ():. PubMed ID: 38606823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.